Search
BCG vaccination modulates immune responses to unrelated pathogens. This off-target effect could reduce the impact of emerging pathogens. As a readily available, inexpensive intervention that has a well-established safety profile, BCG is a good candidate for protecting healthcare workers (HCWs) and other vulnerable groups against COVID-19.
Early 7vPCV schedules have limited impact on pneumococcal vaccine type carriage in PNG
Differences in pneumococcal serotypes, genotypes, and antimicrobial susceptibility between Aboriginal and non-Aboriginal children living in the same area
The prevalence of human rhinovirus (RV) species in children hospitalised with pneumonia in Manhiça, Mozambique
Pneumococcal surface protein A is immunogenic and natural anti-PspA immune responses are acquired through exposure and develop with age
RV-A and RV-C are endemic in South African children and HIV infection may be protective against RSV and bronchiolitis.
The benefits that swimming pools may bring to to ear and eye health in remote Aboriginal communities remains unresolved
The PneuCarriage project, a large, international multi-centre study for the identification of the best pneumococcal serotyping methods for carriage studies
The impact of the 23vPPV booster on IPD incidence among Australian Indigenous children is unclear from regional reports of small case numbers.
Australian Aboriginal people have among the highest rates of invasive pneumococcal disease (IPD) worldwide. This paper investigates clinical diagnosis, risk...